Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 5, 2005, Pages 417-422

  Schwab, D ^a   Grauer, M ^a   Hahn, E G ^a   Muhldorfer S ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN;

ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL INFECTION; BILE DUCT OBSTRUCTION; BILE SECRETION; BILIARY TRACT INFECTION; CANDIDA; CHOLANGITIS; CLINICAL ARTICLE; CLOSTRIDIA; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG PENETRATION; DRUG SAFETY; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LIVER TOXICITY; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOPHLEBITIS;

AZA COMPOUNDS; BILE; BILIARY TRACT; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; CHOLESTASIS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; QUINOLINES;

EID: 24344509966     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02567.x     Document Type: Article

References (29)

1. Charcot JM. Leçons sur les maladies du foie, des voies biliaires et des reins faites à la Faculté de Médecine de Paris. Recueillies et publliées par Bournville et Sevestre. Paris: Bureax du Progrés Médical & Adrien Delahaye, 1877.
2. Thompson J, Bennion RS, Pitt HA. An analysis of infectious failures in acute cholangitis. HPB Surg 1994; 8: 139-44; discussion 45.
3. Gigot JF, Leese T, Dereme T, Coutinho J, Castaing D, Bismuth H. Acute cholangitis. Multivariate analysis of risk factors. Ann Surg 1989; 209: 435-8.
4. Lee DW, Chan AC, Lam YH, et al. Biliary decompression by nasobiliary catheter or biliary stent in acute suppurative cholangitis: a prospective randomized trial. Gastrointest Endosc 2002; 56: 361-5.
5. Demling L, Koch H, Classen M, et al. Endoscopic papillotomy and removal of gall-stones: animal experiments and first clinical results (author's transi.). Dtsch Med Wochenschr 1974; 99: 2255-7.
6. Lai EC, Mok FP, Tan ES, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992; 326: 1582-6.
7. Lee DW, Chung SC. Biliary infection. Baillieres Clin Gastroenterol 1997; 11: 707-24.
8. Leung JW, Ling TK, Chan RC, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994; 40: 716-21.
9. van den Hazel SJ, de Vries XH, Speelman P, et al. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother 1996; 40: 2658-60.
10. Standards NCfCL. Methods for Determining Antibacterial Activity of Antimicrobial Agents, vol. 12, no. 19. September. Tentative guideline M26-T. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992.
11. Stass H, Kubitza D. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man. J Antimicrob Chemother 1999; 43 (Suppl. B): 83-90.
12. Keating GM, Scott LJ. Moxifloxacin: a review of its use in the management of bacterial infections. Drugs 2004; 64: 2347-77.
13. MacGowan AP, Bowker KE, Holt HA, Wootton M, Reeves DS. Bay 12-8039, a new 8-methoxy-quinolone: comparative in vitro activity with nine other antimicrobials against anaerobic bacteria. J Antimicrob Chemother 1997; 40: 503-9.
14. Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 1997; 40: 639-51.
15. Chen CY, Shiesh SC, Wu MC, Lin XZ. The effects of bile duct obstruction on the biliary secretion of ciprofloxacin in piglets. Am J Gastroenterol 1999; 94: 2408-11.
16. Yamamoto S, Kubota Y, Takaoka M, et al. The effect of biliary decompression on antibiotic biliary excretion. Hepatogastroenterology 2002; 49: 330-4.
17. Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004; 126: 322-42.
18. Abadia AR, De Francesco L, Guaitani A. Disposition of ciprofloxacin in the isolated perfused rat liver. Drug Metab Dispos 1995; 23: 197-200.
19. Lowes S, Simmons NL. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells. Br J Pharmacol 2002; 135: 1263-75.
20. Yamaguchi H, Yano I, Saito H, Inui K. Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2. Eur J Pharmacol 2001; 431: 297-303.
21. Schrenk D, Gant TW, Preisegger KH, Silverman JA, Marino PA, Thorgeirsson SS. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 1993; 17: 854-60.
22. Wenzler S, Schmidt-Eisenlohr E, Daschner F. Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections. Chemotherapy 2004; 50: 40-2.
23. Edmiston CE, Krepel CJ, Seabrook GR, et al. In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections. Antimicrob Agents Chemother 2004; 48: 1012-6.
24. Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 2002; 56: 885-9.
25. Subhani JM, Kibbler C, Dooley JS. Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 1999; 13: 103-16.
26. Keighley MR, Drysdale RB, Quoraishi AH, Burdon DW, Alexander-Willians J. Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum. Gut 1976; 17: 495-500.
27. van Lent AU, Bartelsman JF, Tytgat GN, Speelman P, Prins JM. Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc 2002; 55: 518-22.
28. Born P, Rosch T, Bruhl K, et al. Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage. Z Gastroenterol 2000; 38: 483-9.
29. Hintze RE, Adler A, Veltzke W, et al. Clinical significance of magnetic resonance cholangiopancreatography (MRCP) compared to endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1997; 29: 182-7.